Silvia Marsoni - Researcher Profile | RDL Research Database

Publications

2 shown

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Marina Chiara Garassino , Olga Martelli , Massimo Broggini +17 more

2013 The Lancet Oncology 475 citations

Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin

C. Mangioni , Giorgio Bolis , S. Pecorelli +10 more

The aim of this multicenter randomized trial was to compare carboplatin (400 mg/m2) and cisplatin (100 mg/m2) in patients with untreated advanced epithelial ovarian cancer. Toxi...

1989 JNCI Journal of the National Cancer I... 143 citations

Frequent Co-Authors

Gabriella Farina

Silvio Veronese

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Eliana Rulli

Mario Negri Institute for Pharmacological Research

Researcher Info

h-index: 2
Publications: 2
Citations: 618
Institution: Candiolo Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-5361-7122

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.